Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab

PURPOSE: Panitumumab monotherapy is approved for chemotherapy-refractory wild-type KRAS metastatic colorectal cancer (mCRC). Patient-reported outcomes—although important in the palliative setting—have not been reported in this patient population. METHODS: In a phase 3 trial (n = 463), patients with...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Odom, Dawn, Barber, Beth, Bennett, Lee, Peeters, Marc, Zhao, Zhongyun, Kaye, James, Wolf, Michael, Wiezorek, Jeffrey
格式: Artigo
語言:Inglês
出版: Springer-Verlag 2010
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3024508/
https://ncbi.nlm.nih.gov/pubmed/21190026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00384-010-1112-5
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍